K. Ann Caudell, PhD, ACNP - BC. * Identify patients with out-of-range CBGs * Assist in maintaining CBGs between 80 mg/dL & 180 mg/dL during hospitalization.

Slides:

Advertisements

Similar presentations

Using the Insulin Subcutaneous Order & Blood Glucose Record – Adult

Advertisements

Inpatient Hyperglycemia Management

Advanced Pumping. Objectives: Identify situations to utilize temporary basal rate in pump therapy patients. Identify examples of when to use combination.

In-Patient Management of Hyperglycemia Rey Vivo, MD Assistant Professor of Medicine Texas Tech University Health Sciences Center.

Introducing The SHINE Trial (Stroke Hyperglycemia Insulin Network Effort) An Overview for Clinical Nurses NIH-NINDS U01 NSO69498.

MMI Task Force on Diabetes House Staff Curriculum.

Stepwise approach to inpatient diabetes management Erin Keely.

Quick Pump Facts o Constantly provides insulin o Pager-sized “mini-computer” worn outside the body o Pump itself is attached to your body by a small cannula.

Glycemic Control in Acutely Ill Patients Martin J. Abrahamson, MD FACP Associate Professor of Medicine, Harvard Medical School Senior Vice President for.

Putting Pump Policies Into Practice- Case Study Conference Call Elizabeth Blair, ANP-BC,CDE Joyce Lekarcyk, RN, CDE.

INPATIENT DIABETES GUIDE Ananda Nimalasuriya M.D..

Correction Insulin for Inpatient Hyperglycemia Estelle Lin June 2012.

Clinical Protocol Using Insulin Pump Easy Guideline for Initiating Insulin Pumps on Type 2 Diabetes Patients.

Insulin therapy.

Insulin Prescribing.

4-07 CHANGE IS GOOD: THE BASAL BOLUS INSULIN CONCEPT Management of Hyperglycemia in the Adult Hospitalized Patient: Admission to Discharge TEAM MEMBERS:

Kathryn A. Hanavan ANP-BC; BC-ADM Harold Schnitzer Diabetes Health Center September 12,

GENE THERAPY FOR DIABETES Lindsey Rowbotham Period 7.

Are You A Candidate For An Insulin Pump?

Management of Inpatient Blood Glucose at Temple Housestaff Orientation 2014.

Australian Commission on Safety and Quality in Health Care

4-06 CHANGE IS GOOD: THE BASAL BOLUS INSULIN CONCEPT Management of Hyperglycemia in the Adult Hospitalized Patient TEAM MEMBERS: Physicians: Maryann Emanuele,

Diabetes Technology Update

Module 3 Initial Recognition, Triaging, and Management of Hyperglycemia Diabetes Special Interest Group Georgia Hospital Association.

Insulin Information The Basal-Bolus concept

Titrating Insulin to Glycemic Target Judy Bowen, MD CIM Rotation September, 2006.

MANAGEMENT OF THE HOSPITALIZED TYPE I DIABETIC PATIENT Riverside Methodist Hospital January 23, 2014 Rundsarah Tahboub, MD.

Diabetes Past Present and Future Rich Hartmann 5/11/2010.

Inpatient Glycemic Management

The Basics of Insulin Pump Therapy Diabetes Care Center Patty Lord, RN,BSN, CDE Joyce Jones, RN,BSN,CDE Revised 8/2012.

Davida F. Kruger, MSN,APN-BC,BC-ADM Certified Nurse Practitioner Division of Endocrinology, Diabetes, Bone and Mineral Disorders Henry Ford Health System.

Achieving Glycemic Control in the Hospital Setting Part 4 of 4.

Basal Bolus: The Strategy for Managing All Diabetes Fall, 2003 Paul Davidson, MD, FACE Atlanta Diabetes Associates Atlanta, Georgia.

Module 41 Module 4 Pharmacologic Management of Hyperglycemia in the Hospital Part 1: Understanding How to Use Insulin Diabetes Special Interest Group Georgia.

Hypoglycemia & Hyperglycemia Dave Joffe, BSPharm, CDE, FACA Part 4.

Endocrine and Metabolic Disorders Lectures 8 I.Kuziv, MD, PhD.

Type I Diabetes Mellitus

INSULIN PUMPS Shelby Polk DNP, FNP-BC, CDE. 2 MANAGEMENT OF DIABETES IN SCHOOLS Exercise Legal Rights Health & Learning Nutrition Insulin Administration.

1 Module 5 Pharmacologic Management of Hospital Hyperglycemia: Insulin Management Part 2 Diabetes Special Interest Group Georgia Hospital Association.

Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes A pilot, randomized,

1 Challenges and Opportunities In Managing Diabetes and Hyperglycemia Module 2 Diabetes Special Interest Group Georgia Hospital Association.

Insulin Pump Therapy Bruce W. Bode, MD and Sandra Weber, MD.

Achieving Glycemic Control in the Hospital Setting

ADDITIONAL SLIDES FOR ASSIST WITH COMPREHENSION OF LAB CONTENT-MODULE FIVE-DM DENISE TURNER, MS-N.ED, RN, CCRN.

ESOPHAGEAL DIVERTICULUM.  * An esophageal diverticulum is an outpouching of the esophageal wall.

Who is considered elderly? “Young old” years “Old, old” >75 years.

DIABETIC KETOACIDOSIS Emergency pediatric – PICU division H. Adam Malik Hospital – Medical School University of Sumatera Utara 1.

Insulin order sets – only way to order sustained insulin. Separate versions for 1 st time order and revision.

Special Situations In The Management Of In-Patient Hyperglycemia

Lesson One Cabin/ Archery Station (Vocabulary). Doctor’s Video What is Type-1 Diabetes What causes Type-1 Diabetes What are the symptoms How is it diagnosed.

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocol Cases.

The X-pert Diabetes programme Angela Harding and Jane Pares.

Introduction Subcutaneous insulin absorption is not reproducible and insulin entry directly into the circulation is not linked to glucose sensing Basal.

This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.

New Subcutaneous Insulin Protocol for Type 2 Diabetics

Inpatient Glycemic Management

EndoTool IV Physician User Guide Content Expert:

Management of diabetes mellitus in hospitalized patients

Recommendation In people with clinical cardiovascular disease in whom glycemic targets are not met, a SGLT2 inhibitor with demonstrated cardiovascular.

T1DM: Insulin Initiation

For patients with diabetes, a single hospitalization may involve multiple transitions. For patients with diabetes, a single hospitalization may involve.

Clinician Materials For Your Reference

A: Subcutaneous insulin therapy may be selected as continuation of ambulatory therapy, as new therapy, or as a transition plan from intravenous infusion.

Insulin Delivery Systems Atlanta Diabetes Associates

Inpatient Insulin Management on the Wards

Insulin in Type 2 Diabetes

MANDATORY INSULIN EDUCATION

Presentation transcript:

K. Ann Caudell, PhD, ACNP - BC

* Identify patients with out-of-range CBGs * Assist in maintaining CBGs between 80 mg/dL & 180 mg/dL during hospitalization * Assist teams with insulin treatment for newly diagnosed patients or those with continued elevated CBGs * Promote the appropriate use of basal bolus insulin * Assist teams in difficult glycemic control of patient with infections, taking steroids, high glucose dialysate, and those on tube feedings * Provide a safe transition from inpatient to outpatient glycemic control

* Weight-based calculation * Wt. X.2 for patients with renal insufficiency * Wt. X for patients of normal weight * Wt. X.6 for patients overweight * Wt X for obese patients For those patients newly diagnosed, start with conservative doses to determine patient’s sensitivity (or lack of ) to insulin.

* For patients on steroids, evaluate CBG trends * Frequently will have  CBGs throughout day * NPH recommended in this case to provide coverage for ~ 12 hours

* Infections  CBGs * Increased insulin requirements * Calculate total daily insulin requirements including correctional doses to determine basal and nutritional doses

* Represents a challenge for glycemic control * Issues include 1. temporary tube feeding catheters such as Dobhoffs due to frequency of occlusion or misplacement 2. nocturnal tube feedings when patient beginning to eat meals in that nutritional insulin is considered for meals but not during nighttime feedings * In this case, can continue to give correctional doses every four hours, or regular insulin every six hour

* When more permanent feeding tubes are inserted, can consider the following: 1. Determine patients insulin requirements and determine basal and nutritional doses 2. Nutritional dose options include: * Lispro every 4 hours * Regular every 6 hours * NPH every 12 hours * Eventually putting all insulin doses into the basal insulin * This requires careful monitoring 3. During periods of the patient being NPO, D5W should be administered at the rate of the tube feeding and all nutritional doses should be suspended

* K. Ann Caudell * Cell phone: * Pager: * Availability 9:00 AM to 1:00 PM * If after 1:00 PM, please contact internal medicine * Please either call my cell or page me if you need assistance.